An Update on The Economic Impact of Adult Immunisation
By Staff Writer
April 24, 2024
Introduction: The Value of Adult Immunisation in Health Economics
In the face of mounting pressures on global healthcare systems, adult immunisation programmes emerge as a beacon of fiscal responsibility and preventative wisdom. Recent research from the Office of Health Economics (OHE) has illuminated the substantial economic benefits these programs offer across ten diverse countries including Australia, Brazil, Germany, South Africa, Thailand, and the United States. With a return on investment of up to 19 times the initial outlay, the impact of adult immunisation stands as an exemplar of preventive healthcare, contributing to the development of a stronger and more resilient society.
Figure 1. Ten Countries Selected for this Analysis.
The Burden of Vaccine-Preventable Diseases
Vaccine-preventable diseases continue to exert a significant toll on adult populations worldwide. The OHE research underscores the heavy impact of conditions like seasonal influenza, pneumococcal disease, and others on healthcare systems. Adult immunisation programs offer a formidable shield against these diseases, averting severe health outcomes and mortality, especially among the elderly and those with chronic conditions.
Adult Immunisation Economic Impact
The economic modelling conducted by the OHE reveals that adult immunisation programs are not only health-preserving but also cost-saving. By preventing hospitalisations and emergency care, these programs can lead to net cost savings for healthcare systems. For instance, one full vaccination course can yield up to $4637 in net monetary benefits per individual.
Societal and Productivity Gains
Beyond healthcare savings, adult immunisation programs contribute to societal wealth. By preventing disease, they enable individuals to maintain productivity, reducing the economic burden on caregivers and the wider community. This aligns with the broader goals of health and economic equity, particularly benefiting underserved communities.
Figure 2. Percentage of Countries for with Evidence of Positive Impact on Value
Recommendations and Future Directions
The OHE report culminates in key recommendations, advocating for a prevention-first approach and robust funding for adult immunisation. It calls for the expansion of these programs as part of a life-course immunisation strategy, emphasising the need for further research to fill existing evidence gaps and inform policy decisions.
Conclusion
Adult immunisation programs are a cornerstone of preventive healthcare, offering unmatched economic benefits. As healthcare systems confront increasing demands, these programs stand as a testament to the power of prevention, offering a sustainable path forward for societies worldwide
🚨 *What does the U.S. withdrawing from the WHO mean for global health?*
President Trump’s executive order to begin the withdrawal process raises serious concerns about the future of global health security. From financial disparities to a shift in international partnerships, the implications could reshape our collective ability to combat pandemics and health crises.
Dive into our article to understand the potential impacts on health outcomes and the quest for new alliances.
The European Medicines Agency’s PRAC is currently reviewing the potential risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with semaglutide-containing medicines, including popular treatments like Ozempic and Wegovy. With recent studies yielding conflicting evidence, this review is crucial for patient safety and the future of these therapies.
Read the full article to understand the implications and what this could mean for healthcare providers and patients alike!
💡 *Are single-visit cervical cancer screenings the key to better health outcomes in high HIV prevalence areas?*
A recent study from KwaZulu-Natal, South Africa reveals that repeat single-visit cervical cancer screening using HPV DNA testing is not only the most effective but also the most cost-effective approach for women living with HIV. This aligns with WHO recommendations for comprehensive cervical cancer elimination strategies.
Explore the insights and implications of this vital research that could transform cervical cancer prevention in resource-limited settings.
When you partner with Syenza, it’s like a Nuclear Fusion.
Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in
health policy, health economics, systems analysis, public finance, business, and project management.
You’ll also feel our high-impact global and local perspectives with cultural intelligence.
